Role of atrial fibrillation burden in assessing thromboembolic risk

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1223-9. doi: 10.1161/CIRCEP.114.001356.

¹ From the Department of Cardiovascular Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (P.Z., J.W.W., E.R.E.); Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Chicago, IL (R.S.P.); and Division of Cardiology, Hackensack University Medical Center, NJ (T.V.G.). pzimetba@bidmc.harvard.edu.
² From the Department of Cardiovascular Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (P.Z., J.W.W., E.R.E.); Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Chicago, IL (R.S.P.); and Division of Cardiology, Hackensack University Medical Center, NJ (T.V.G.).

No abstract available

Keywords: anticoagulation; atrial fibrillation; ischemic; stroke; thromboembolism.

Publication types